Key result
NSTEMI linked to ~28% higher post-discharge mortality compared to STEMI.
Why the study?
Do patients discharged alive after NSTEMI have a higher risk of long-term post-discharge all-cause mortality compared to patients discharged after STEMI in a community-based population?
Cohort (n=3,762)
Yes
Do patients discharged alive after NSTEMI have a higher risk of long-term post-discharge all-cause mortality compared to patients discharged after STEMI in a community-based population?
In a large community-based cohort, patients discharged after NSTEMI had significantly worse short- and long-term post-discharge survival than those with STEMI, highlighting the need for close post-discharge surveillance and aggressive secondary prevention in NSTEMI patients.
Answers are grounded in this paper and cite their sources.
Supports caution on post-discharge prognosis after NSTEMI versus STEMI; leaves open whether targeted interventions improve survival.
BACKGROUND: Limited recent data are available describing differences in long-term survival, and factors affecting prognosis, after ST-segment elevation myocardial infarction (STEMI) and non-ST-segment elevation myocardial infarction (NSTEMI), especially from the more generalizable perspective of a population-based investigation. The objectives of this study were to examine differences in post-discharge prognosis after hospitalization for STEMI and NSTEMI, with a particular focus on factors associated with reduced long-term survival. METHODS: We reviewed the medical records of residents of the Worcester, MA, USA metropolitan area hospitalized at eleven central Massachusetts medical centers for acute myocardial infarction (AMI) during 2001, 2003, 2005, and 2007. RESULTS: A total of 3762 persons were hospitalized with confirmed AMI; of these, 2539 patients (67.5%) were diagnosed with NSTEMI. The average age of study patients was 70.3 years and 42.9% were women. Patients with NSTEMI experienced higher post-discharge death rates with 3-month, 1-year, and 2-year death rates of 12.6%, 23.5%, and 33.2%, respectively, compared to 6.1%, 11.5%, and 16.4% for patients with STEMI. After multivariable adjustment, patients with NSTEMI were significantly more likely to have died after hospital discharge (adjusted hazards ratio 1.28; 95% confidence interval 1.14-1.44). Several demographic (eg, older age) and clinical (eg, history of stroke) factors were associated with reduced long-term survival in patients with NSTEMI and STEMI. CONCLUSIONS: The results of this study in residents of central Massachusetts suggest that patients with NSTEMI are at higher risk for dying after hospital discharge, and several subgroups are at particularly increased risk.
No takes yet. Share an insight, caveat, or question.
Goldberg et al. (2013) conducted a cohort in Acute myocardial infarction (STEMI and NSTEMI) surviving to hospital discharge (n=3,762). Non-ST-segment elevation myocardial infarction (NSTEMI) vs. ST-segment elevation myocardial infarction (STEMI) was evaluated on Post-discharge all-cause mortality (HR 1.28, 95% CI 1.14-1.44, p=<0.05). NSTEMI patients had a higher risk of post-discharge all-cause mortality compared to STEMI patients.
Synapse has enriched 10 related papers. Consider them for comparative context: